Resultados de la búsqueda 731-740 of 9478 for monoclonal antibody
... antibody) * Olaparib (a type of PARP inhibitor). A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments ...
Evaluate the influence of the critical shoulder angle (CSA) on outcomes after total anatomic shoulder arthroplasty; and; Evaluate the influence of the critical ...
... antibody) * Olaparib (a type of PARP inhibitor). Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors.
The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...
... antibody) * Olaparib (a type of PARP inhibitor). A Study Of An MMSET Inhibitor In Patients With Relapsed And Refractory Multiple Myeloma. Jacksonville, Fla ...
This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...
Rochester, Minn. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or ...
Los investigadores de Mayo Clinic acuñaron el término gammapatía monoclonal de significado incierto. Han estado estudiando el trastorno durante décadas. El ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?